Report cover image

Global Markets for Infectious Disease Treatments

Publisher BCC Research
Published Jul 03, 2025
Length 186 Pages
SKU # WA20212895

Description

Report Scope

This report offers an analysis of the global market for infectious disease therapeutics, vaccines, and diagnostics. The infectious diseases covered in the report include human immunodeficiency virus (HIV) infection, seasonal influenza (including influenza A and B), hepatitis B, hepatitis C, respiratory syncytial virus (RSV) infection, tuberculosis (TB), herpes simplex virus (HSV) infection, malaria, rotavirus infection, and viral hemorrhagic fevers such as yellow fever, dengue, Lassa fever, Ebola fever, and Zika fever.

The report’s estimates of the infectious disease market include global revenue ($ millions) for the base year of 2024, estimates for 2025, and data for the forecast period of 2026 through 2030. The report focuses on the major trends, challenges and opportunities in the market and vendor landscape. It also covers the new products, acquisitions, and collaborations related to the market. The report also analyzes environmental, social, and corporate governance (ESG) developments.

The report concludes with an analysis of the competitive landscape, which provides a ranking by market share of leading companies in the market. There is also a section of profiles of the leading companies.

Outside the scope of the report are vector/mosquito control approaches, strategies and products, drugs used for symptomatic treatment and not for the elimination of the virus from the host, and details on suppliers of generics and non-branded generics. Also excluded are markets for hospital-based diagnosis that are not carried out by kits (for example, malaria slide smear-based tests), as well as discussion of the spread of vector-borne infection (such as malaria) via blood transfusion.

Report Includes

53 data tables and 69 additional tables

A review of the global market for infectious disease treatments in the healthcare and pharmaceutical industry

Analyses of the global market trends, with sales data from 2022-2024, estimates for 2025, and projected CAGRs through 2030

Evaluation and forecast of the overall market size in terms of dollar value terms, and corresponding market share analysis based on product type, disease type, and geographic region

An evaluation of the market potential for infectious disease treatments, opportunities and gaps, estimating current and future demand

Discussion of new drugs and innovations in chemical compounds, vaccines and biologicals and diagnostic kits that are recently launched or in development

Review of key patent grants and new technologies related to innovations in infectious disease treatments

Identification of challenges and discussion of how to overcome these to be able to reach commercialization potential, and ESG trends of the market

Market share analysis of the key companies of the industry and coverage of their proprietary technologies, strategic alliances, and other key market strategies and a relevant patent analysis

Profiles of the leading companies, including Gilead Sciences Inc., GSK plc., Sanofi, Merck & Co. Inc., and Abbott

Companies Mentioned

ABBOTT
ABBVIE INC.
CSL
DANAHER CORP.
F. HOFFMANN-LA ROCHE LTD.
GILEAD SCIENCES INC.
GSK PLC
JOHNSON & JOHNSON SERVICES INC.
MERCK & CO. INC.
MOLBIO DIAGNOSTICS LTD.
ORASURE TECHNOLOGIES INC.
PFIZER INC.
SANOFI
SERUM INSTITUTE OF INDIA PVT. LTD.
SIEMENS HEATHINEERS AG

Table of Contents

186 Pages
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Market Dynamics
Emerging Trends
Analysis by Segment
Analysis by Region
Conclusion
Chapter 2 Market Overview
Infectious Diseases
Management of Infectious Diseases
Antimicrobial Resistance
Disease Overviews
Human Immunodeficiency Virus
Influenza
Hepatitis
Respiratory Syncytial Virus
Tuberculosis
Herpes Simplex Virus
Malaria
Rotavirus
Viral Hemorrhagic Fevers-Yellow Fever
Viral Hemorrhagic Fevers-Dengue
Viral Hemorrhagic Fevers-Lassa Fever
Viral Hemorrhagic Fevers-Ebola Fever
Viral Hemorrhagic Fevers-Zika Virus
Analysis of Macroeconomic Factors
Impact of U.S. Tariffs on the Pharmaceutical Industry
Global Economic Growth
Demographic Trends
Porter's Five Forces Analysis
Bargaining Power of Buyers (Moderate to High)
Bargaining Power of Suppliers (Moderate to Low)
Threat of New Entrants (Moderate to Low)
Threat of Substitutes (Low)
Level of Competitiveness (High)
Chapter 3 Market Dynamics
Market Dynamics
Market Drivers
Resistance to Drugs
Global Efforts to Combat Infectious Diseases
Technological Advances
Climate Change
International Travel
Market Restraints
Loss of Exclusivity and Genericization
Pricing Pressures
Lack of Awareness and Underdiagnosis
Market Trends
Long-acting Injectable Medicines
Self-Testing Kits
Chapter 4 Regulatory Landscape
Regulatory Aspects
U.S.
European Union
Japan
Regulatory Aspects of Infectious Disease Diagnostics
U.S.
EU
Japan
Chapter 5 Emerging Technologies and Developments
Emerging Technologies
Multiplex PCR Syndromic Testing
NGS and Genetic Medicine
Pipeline Analysis
Takeaways
Novel Therapeutic Agents in Phase 3 Development
Chapter 6 Market Segmentation Analysis
Segmentation Breakdown
Global Infectious Disease Treatment Market, by Product
Therapeutics
Vaccines
Diagnostics
Global Infectious Disease Treatment Market, by Disease
HIV/AIDS
Influenza
Hepatitis B
Hepatitis C
Respiratory Syncytial Virus
Tuberculosis
Herpes Simplex Virus
Malaria
Rotavirus
Viral Hemorrhagic Fevers
Geographic Breakdown
Global Infectious Disease Treatment Market, by Region
North America
Europe
Asia-Pacific
Middle East and Africa (MEA)
South America
Chapter 7 Competitive Intelligence
Overview
Infectious Disease Therapeutics Market Shares
Infectious Disease Vaccines Market Share Analysis
Infectious Disease Diagnostics Market Ranking
Chapter 8 Sustainability in Infectious Disease Treatment Industry: An ESG Perspective
Introduction to ESG
ESG Issues Specific to the Infectious Disease Treatment Market
Global Health Access and Equity
R&D for Neglected and Emerging Infectious Diseases
Antimicrobial Stewardship
Collaborations with Public Health Bodies
Concluding Remarks
Chapter 9 Appendix
Methodology
Sources
Abbreviations
Company Profiles
ABBOTT
ABBVIE INC.
CSL
DANAHER CORP.
F. HOFFMANN-LA ROCHE LTD.
GILEAD SCIENCES INC.
GSK PLC
JOHNSON & JOHNSON SERVICES INC.
MERCK & CO. INC.
MOLBIO DIAGNOSTICS LTD.
ORASURE TECHNOLOGIES INC.
PFIZER INC.
SANOFI
SERUM INSTITUTE OF INDIA PVT. LTD.
SIEMENS HEATHINEERS AG
Emerging Start-ups/Market Disruptors
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.